Church & Crawford Inc. announced that it has commenced the build out of its central fill pharmacy. Located in a 21,000 square foot temperature controlled facility in the western part of the Greater Toronto Area and close to major transportation routes, the pharmacy will be integrated into Church & Crawford's model enabling it to better process prescriptions and to deliver with a lower cost. The magnitude of the space will enable Church & Crawford to scale up for anticipated future growth. Church & Crawford's innovative and unique model will enable it to offer lower drug costs, while delivering quality care that's convenient and tailored to any individual needs. Completing the build of its central fill pharmacy is a critical step towards the implementation of its vision to revolutionize drug plans and patient care management.

Church & Crawford, Inc. accepted Marc Kealey's resignation as a Director to its Board. Due to recent health issues he has decided to tender his resignation as a Director of the company and devote his time to his recuperation.

Church & Crawford Inc. announced the appointment of Marc Kealey as a Director to its Board. Mr. Kealey brings his many years of experience and his expertise to the Board of Directors of Church and Crawford Inc. With over 20 years experience in healthcare, Marc is an expert on health reform and health governance in Canada. As recently as spring 2007, Marc was CEO of the professional organization for pharmacists in Canada.